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Abstract
A new approach for the selective comparative metabolite profiling of carboxylic acids in rat urine
was established using capillary electrophoresis-mass spectrometry (CE-MS) and a method for
positively pre-charged and 2H-coded derivatization. Novel derivatizing reagents, N-alkyl-4-
aminomethylpyridinum iodide (alkyl=butyl, butyl-d9 or hexyl), containing quaternary amine and
stable isotope atoms (deuterium), were introduced for the derivatization of carboxylic acids. CE
separation in positive polarity showed high reproducibility (0.99 –1.32% RSD of migration time)
and eliminated problems with capillary coating known in CE-MS anion analyses. Essentially
complete ionization and increased hydrophobicity after the derivatization also enhanced MS
detection sensitivity (e.g. formic acid was detected at 0.5 pg). Simultaneous derivatization of one
sample using two structurally similar reagents, N-butyl-4-aminomethylpyridinum iodide (BAMP)
and N-hexyl-4-aminomethylpyridinum iodide (HAMP), provided additional information for
recognizing a carboxylic acid in an unknown sample. Moreover, characteristic fragmentation
acquired by online CE-MS/MS allowed for identification and categorization of carboxylic acids.
Applying this method on rat urine, we found 59 ions matching the characteristic patterns of
carboxylic acids. From these 59, 32 ions were positively identified and confirmed with standards.
For comparative analysis, 24 standard carboxylic acids were derivatized by chemically identical
but isotopically distinct BAMP and BAMP-d9, and their derivatization limits and linearity ranges
were determined. Comparative analysis was also performed on two individual urine samples
derivatized with BAMP and BAMP-d9. The metabolite profiling variation between these two
samples was clearly visualized.
Keywords
Metabolomics; Carboxylic acid derivatives; CE; Group Specific Internal Standard Technology
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1 Introduction
Metabolomics is the comprehensive study of metabolites under a given set of conditions
[1,2]. The most popular techniques employed for metabolomic studies include NMR
spectroscopy and mass spectrometry [3-7]. Although considerable advances have been made
in the development of metabolomic tools, it is commonly believed that a fully
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comprehensive analysis of metabolite's is unfeasible [8-10]. This pessimism arises from the
complexity (as many as 200,000 metabolites arise in plants) [11], chemical diversity
(molecular weight, polarity, solubility) and physical properties of the average metabolome.
A further complication is the broad concentration range of metabolites [12].
Metabolite profiling is an alternative to NMR and MS for metabolomics focusing on sub-
metabolome studies that involve identification and quantification of a pre-defined set of
metabolites, generally related to a specific metabolic pathway(s) [12]. Profiling a selected
group of metabolites is an important indicator of normal and pathological phenotypes
[13,14], and may lead to biomarker discovery. Urinary carboxylic acids represent such a
selected group of metabolites. Profiling urinary carboxylic acids provides information on the
pathophysiological status of various diseases, such as organic acidurias, diabetes mellitus, or
kidney and liver disorders. Carboxylic acids are usually analyzed using GC [15]. Most
HPLC-related reports on this group of compounds target specific carboxylic acids [16,17].
Comprehensive carboxylic acid analysis in bio-fluids is rarely seen. Recently, Lafaye
reported metabolite profiling in rat urine using LC-MS that included characterization of
some carboxylic acids, such as hippuric acid, ferulic acid and sebacic acid [17]. One
limitation of LC-MS methods based on reversed phase chromatography is poor resolution,
probably due to the strong polarity of carboxylic acids. The second limitation is lack of
sensitive quantification due to iosnization suppression. It has been demonstrated that
common mobile phase modifier, such as formic acid, in reverse phase HPLC suppresses the
ionization efficiency of carboxylic acids in ion source when MS is operated in negative
mode, hence, reduces the detection sensitivity [18]. Similarly, variable ionization
efficiencies of analytes also means that MS is unable to provide absolute quantification.
Although it is routine to quantify targeted molecules using stable-isotope internal standards
or their structural analogs, this approach is neither routine nor simple in metabolite profiling.
A widely use strategy to circumvent this problem is comparative quantification using in vivo
isotope labeling with 2H, 13C, or 15N labeled substrates. Although this strategy is well
recognized in model systems such as E. coli, yeast, algae, fungi, and plants [19-21], it is
difficult to apply in animal and human studies.
To address the quantification issue, we developed a new MS-based strategy for comparative
metabolomics called Group Specific Internal Standard Technology (GSIST) [18, 22, 23].
Quantification in GSIST is accomplished by derivatization of metabolites of interest with
isotopically coded reagents. These reagents usually have permanent positive charges and
length-adjustable alkyl chains that enhance their ionization efficiency and increase their
hydrophobicity [23-26]. This method also allows for comparative quantification which is
accomplished by comparing individually derivatized samples with chemically identical, but
isotopically distinct, labeling reagents. Absolute quantification of target metabolites can also
be achieved by mixing an isotope-coded experimental sample with a known amount of
standard derivatives [22]. In this report, we expand this methodology to carboxylic acid
profiling using CE-MS and novel derivatizing reagents, N-alkyl-4-aminomethylpyridinum
iodide.
CE-MS is an analytical tool characterized by high separation efficiency, increased detection
sensitivity, low sample and solvent consumption, and short analysis time [27-29].
Interestingly, only a few studies evaluating carboxylic acids with CE-MS have been reported
[29-33]. This is most likely because small carboxylic acids have a strong negative
electrophoretic mobility that makes CE-MS analysis difficult. In CE, ionic species are
separated based on their charge and size (mobility in the electric field). Carboxylic acids
migrate from cathode to anode, opposite to the direction of electroosmotic flow (EOF), and
at a higher migration rate than the EOF rate under ordinary conditions. Therefore, they are
usually separated in a co-EOF mode using a cation-coated capillary (dynamic or covalent
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coating) and reversed polarity. However due to problems with dynamic coatings, this
strategy is a challenge in CE-MS. Coatings formed by dynamical adsorption of a cationic
surfactant, such as by using cetyltrimethylammonium bromide (CTAB) in the background
electrolyte (BGE), are unstable in the CE-MS system. This is because the CE-MS system
does not possess an outlet vial with BGE that can provide a continuous source of CTAB. As
a consequence, CTAB desorbs from the wall and migrates to the inlet (cathode). This leaves
unsequestered silanol groups (SiO-) in the column that generate normal EOF toward the
cathode (away from the MS). Beyond changing analyte migration rates this can create a
liquid void at the capillary exit that interrupt the separation process[34]. To overcome this
issue, a permanently coated capillary is required. Disadvantages are that this type of
capillary is more expensive and the stability of most coatings strongly depends on the
running pH, even though some coatings are indeed pH indsependent [29].
An alternative solution described in this paper that changes the chemical and physical
properties of carboxylic acids using a positively charged derivatizing agent. After
derivatization, these positively charged derivatives always migrate to the cathode, which
allows CE-MS to operate in the normal CE mode with the cathode at the column outlet.
Capillary modification is unnecessary, which makes the analytical process simpler and more
robust. The permanent positive charge also eliminates the effects of pH and BGE on the
charge status of analytes. Operating pH of the BGE can then be optimized over a wide
range. Particularly important is that formic acid, a commonly used BGE, can be used
without any limitations. For anion analysis by CE-MS, ammonium acetate at pH >8.5 has
frequently been used as a BGE [29,35]. However, the detection sensitivity for anions in CE-
MS using ammonium acetate is several-fold lower than that of cations [29]. We think this is
a result of ion suppression by acetate. A second advantage to our approach is that positively
charged carboxylic acid derivatives will migrate faster than the underivatized neutral or
negative species (in front of the sample zone) and suppress ionization efficiency of positive
ions, resulting in a highly selective analysis in a shorter time. In addition, enhanced MS
detection by extending alkyl chain length and comparative quantification using deuterium
coding are included in this approach.
2 Materials and methods
2.1 Chemicals
All standard carboxylic acids, methanol, 4-aminomethylpyridine, alkyl iodide, N-ethyl-N′-
(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC), HBr (68%, v/v) and phthalic
anhydride were purchased from Sigma-Aldrich (St. Louis, MO). 1-iodobutane-d9 was
purchased from Cambridge Isotope Laboratories (Andover, MA).
The procedure for synthesis of N-butyl-4-aminomethylpyridinium iodide (BAMP) and N-
hexyl-4-aminomethylpyridinium iodide (HAMP) was adapted from Bardsley [36]. Briefly,
15 g of phthalic anhydride (100 mmol) was mixed with 10 ml of 4-aminomethylpyridine
(100 mmol) and incubated for 30 min at 170°C. The product, crude phthalimido compound,
was recrystallized from methanol and 5 g (about 20 mmol) dissolved in 20 ml methanol with
either iodobutane (88 mmol, BAMP) or iodohexane (67 mmol, HAMP) in a 1:1 ratio. To
complete the synthesis, the reaction was refluxed for 48 (BAMP) or 72 hr (HAMP). The
solution was cooled to room temperature, the solvent removed by evaporation under
vacuum, and the solid phase recrystallized from acetone. The purified crystals were refluxed
in 20 ml HBr (68%, v/v) for 6 hours followed by addition of 10 ml water. The solution was
filtered to remove phthalic acid, the filtrate extracted with ether (2 × 10 ml) and the extract
evaporated to dryness under vacuum. The products (BAMP or HAMP) were recrystallized
from acetone. N-butyl-d9-4-aminomethylpyridinium iodide (BAMP-d9) was synthesized
using the same procedure, with the substitution of iodobutane-d9 for iodobutane.
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2.2 Rat urine sample collection
Sprague Dawley female rats, 7-8 weeks old (weight ∼220 g), purchasesd from Harlan
(Harlan,Indianapolis, IN) were fed ad libitum with a standard rodent diet (Harlan,
Indianapolis, IN). Collected urine was stored at -80°C until analysis.
2.3 Derivatization procedure
Derivatizing reagents and EDC were prepared in water at a concentration of 0.1 M
(derivatization solutions were stored up to one month at 4°C; EDC was prepared fresh
daily). A pooled standard solution of 24 carboxylic acids (0.45 mM each) was prepared in
water. Individual standards (Table 1) contained 10 mM of each carboxylic acid. To establish
the derivatization method, 50 μl of the standard solution was added to 100 μl of a
derivatizing reagent and 100 μl of EDC solution (∼20-fold excess of each). Derivatization
was performed by incubating the mixture for 2 hours at 50°C. For analysis of rat urine
samples, urine was centrifuged for 10 min at 3000 × g, 500 μl of the supernatant was added
to 200 μl of a derivatizing reagent and 15 mg solid EDC. After pH adjustment to a range of
4-6 by titration with either 2 M HCl or 2M NaOH, the samples were incubated for 2 hours at
50°C. For comparative analysis, the samples were derivatized under identical conditions
with BAMP and BAMP-d9 (reaction shown in Figure 1), at various ratios as described
below.
2.4 Solid phase extraction (SPE)
The derivatized compounds were purified using Oasis® WCX cartridges (Waters, Milford,
MA). A cartridge (1 ml) was pre-conditioned by washing with 1 ml of methanol followed by
1 ml water. The samples were diluted with 300 μl of 5% ammonium hydroxide, loaded onto
the cartridge, and washed with an additional 1 ml of 5% ammonium hydroxide and 1 ml of
methanol. The derivatives were eluted with 2% formic acid in methanol (1 ml), dried under
vacuum, and reconstituted to the original volume using CE running buffer.
2.5 CE-MS instrumentation and conditions
A Beckman-Coulter PA800 CE System (Beckman-Coulter, Fullerton, CA) was coupled to a
QStar mass spectrometer (Applied Biosystems; Foster City, CA) through the CE-MS
Upgrade Kit interface (Applied Biosystems/MDS SCIEX; Concord, ON, Canada). Bare
fused silica capillaries (100 cm length, 50 μm ID × 365 μm OD) were used for CE
separations (Polymicro Technologies, Phoenix, AZ). The separation background electrolyte
(BGE) was formic acid (1 M). To gain high electroosmotic flow (EOF) for rapid separation,
each capillary (before connecting CE and MS) was flushed overnight with 0.1 M NaOH,
followed by water and BGE for 10 min. A potential of 30 V/cm was applied off-line for 30
min to precondition columns. Sampling was performed by pressure injection for 5 s at 2 psi.
The separation was carried out at a potential of 30 V/cm, unless otherwise stated. Between
each run, the capillary was flushed for 2 min with 0.1 M NaOH and BGE at 50 psi. Sheath
flow liquid [50% (v/v) methanol with 0.1% (v/v) formic acid in water] was delivered to the
CE-MS sheath flow interface at 1 μl/min using the MS syringe pump.
The MS was operated in the positive mode with scan range of 190 - 500 m/z for BAMP
derivatives or 200 - 500 m/z for HAMP derivatives at 1 scan/s. Optimization of ion source
parameters, sheath flow rate, maximum ESI sensitivity, and stability were achieved using
electrokinetic pumping at a potential of 300 V/cm and 0.2 psi assisting pressure to the
sample vial containing standards in BGE buffer. Typical settings were as follows: ion spray
voltage (IS), 4800 V; curtain gas (CUR), 30; ion source gas 1 (GS 1), 40; ion source gas 2
(GS2), 0; declustering potential (DP), 50 V; focusing potential (FP), 220 V; declustering
potential (DP2), 10 V. Data acquisition was manually started immediately after the
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separation voltage reached the set point. For CE-ESI MS/MS experiments, Information
Dependent Acquisition (IDA) was performed with collision-induced dissociation (CID) The
collision energy and collision gas set at 40 and 5, respectively. Data were acquired and
processed using Analyst software (Applied Biosystems/MDS SCIEX; Concord, ON,
Canada).
3 Results and discussion
3.1 Optimization of derivatization reaction and SPE
For derivatization of carboxyl groups, a variety of reagents have been investigated and
found to be valuable under certain conditions [37]. Besides general considerations for
derivatization reactions such as quantitative yield, mild conditions, stable and identifiable
product, additional requirements may be necessary for our specific situations. Reagents
should have permanent positive charges, and should be easily coded with stable isotopes.
Because both the carboxylic acids and derivatizing reagents are small water-soluble
molecules, performing the reaction in an aqueous solution is ideal. To meet such
requirements, the HAMP, BAMP and BAMP-d9 derivatizing reagents were developed. The
labeling procedure involves initial activation of the carboxyl group by a water-soluble EDC,
and subsequent reaction in aqueous solutions [38].
EDC is a well-known condensing reagent for carboxyl groups. When used in organic
solvents, a catalyst 4-(dimethylamino) pyridine (DMAP) is often used [39,40]. Our
experimental results showed that in aqueous solutions alkaline conditions have little or no
effect on the derivatization reaction, and the optimum pH for derivatization is between 3 and
6, with no need for DMAP. Since the pH of EDC-HCl solution is approximately 4.6 and the
solution has inherent buffering capability, it was not necessary to adjust the reaction pH for
carboxylic acid standards. Derivatization of urine samples, on the other hand, required pH
adjustment to the above-mentioned range. These observations are consistent with previous
reports [38,41]. The optimum yield of the derivatization reaction was reached with
approximately a 20-fold molar excess of both derivatizing reagents and EDC.
Our preliminary CE analyses of these derivatives showed a large broad peak ahead of the
analyte zone in the electrophogram. This front peak diminished separation in that all
dicarboxylic acid derivatives migrated in one peak. The interfering peak was effectively
removed by adding an SPE cleanup step (Figure 2). SPE was carried out with an Oasis®
WCX cartridge packed with bifunctional sorbent (ion exchange and reversed-phase) that
provides superior sample enrichment of strong bases and quaternary amines [42].
3.2 Optimization of CE-MS conditions
The choice of the separation BGE is crucial for CE separation as this has great impact on the
mobility of analytes, EOF, peak shape, and therefore on the overall separation efficiency. In
the case of CE-MS, the composition of BGE also affects MS detection. Since the derivatives
studied here are permanently charged, BGE pH is not an issue in separations. The major
concern is for compatibility with MS analysis. For this reason, formic acid (a common
volatile acid additive for ESI-MS) was used. The impact of formic acid concentration on
separation and MS sensitivity was evaluated in the range of 0.1 M to 2.0 M. With increasing
concentrations of formic acid, up to 1 M, significant improvement in peak shape and MS
sensitivity was observed. Considerable peak broadening was found at formic acid
concentrations less than 0.5 M and was likely due to the ionic interaction between positively
charged analytes and SiO- of the inner capillary wall. Even with a pH as low as 2, silanol
groups on the fused-silica capillary may still exist in anionic form [43]. On the other hand,
concentrations of formic acid greater than 1 M increased the separation current and Joule
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heating, leading to deterioration of the separation. The optimum concentration of formic
acid in BGE was determined to be 1M.
Optimization of the composition and the flow rate of the sheath liquid are also important for
separation and detection. The matrix of sheath liquid must be volatile, and the mixture of
methanol and water is commonly used. On the hand, the choice of electrolytes in sheath
liquid, which provides sheath liquid conductivity, should be carefully made and its
concentration should optimized. Differences in the composition of sheath liquid and BGE of
actual CE separation may create a moving ionic boundary effect, and lead to discontinuous
separation and irreproducible results [44]. This is especially likely under zero-EOF
conditions that would be created with a neutral polymer coated capillary or at a high
concentration of formic acid. To minimize this effect, 50% (v/v) methanol in water
containing 0.1% (v/v) formic acid was used as the sheath liquid.
The effect of sheath flow rate was investigated over the range of 0.5-10 μl/min. As
expected, higher flow rates decreased sensitivity due to dilution in the sample zone. At a
flow rate of 0.5 μl/min, on the other hand, separation current was unstable and occasionally
interrupted. The optimal combination of stable separation current and sensitivity was
achieved at a sheath flow rate of 1.0 μl/min.
3.3 Evaluation of CE-MS analysis with HAMP and BAMP carboxylic acid standard
derivatives
Figure 2 shows the base peak chromatograms of 24 BAMP and HAMP derivatized
carboxylic acid standards including short-chain fatty acids, di- and tri-carboxylic acids,
hydroxyl carboxylic acids, α-keto carboxylic acids, cyclic carboxylic acids and aromatic
carboxylic acids. Di-carboxylic acids were exclusively doubly derivatized. Two types of
derivatives, both double derivatized and dehydrated double derivatized, were found for citric
and isocitric acids. The mechanism for dehydration is not clear. Perhaps lactone is formed
that then dehydrates. Doubly derivatized acids possess two positive charges. This causes
them to migrate faster and appeared at the front of the electropherogram, followed by mono-
derivatized carboxylic acids. Since the HAMP derivatives are larger than BAMP derivatives,
all HAMP derivatives exhibited longer migration times than the corresponding BAMP
derivatives. Although CE was not able to resolve all the carboxylic acids, differentiation
between acids in unresolved peaks was easily achieved in the MS. In addition, CE resolution
of some stereo isomers (fumaric and maleic acids) as well as positional isomers (citric and
isocitric acids) was achieved. Presumably, it could be attributed to the fact that drivatization
make the difference in structure more significant, resulting in better separation.
Unfortunately, the method failed to distinguish butyric and isobutyric acids. These isomers
have exactly the same mass and co-eluted.
The sensitivity and reproducibility of this method were examined by analyzing 24
carboxylic acid standards (Table 1). Based on a signal-to-noise ratio of 3, HAMP derivatives
showed approximately 4- to 5-fold higher sensitivity than BAMP derivatives. This is
consistent with previous observations for amino acid derivatives [23]. I Ionization efficiency
increases with analyte hydrophobicity or with the length of the alkyl chain in the derivative.
Even though the concentration detection limits of CE-MS are mediocre, it was found that the
mass detection limits for HAMP derivatives are superior to HPLC fluorescence based
detection [16]. It was initially observed that migration time gradually decreased during a
series of runs, but satisfactory reproducibility was obtained by replacing the BGE after each
run. Since the BGE is not a buffered solution, a significant pH changes of the BGE due to
electrolysis are expected over time [45]. This will cause a gradual decrease in EOF.
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3.4 Determination of carboxylic acids in rat urine
Pooled rat urine was used to examine the capability of the developed CE-MS method in a
real biological system (base peak chromatograms are shown in Figure 3). Aliquots of sample
were derivatized with BAMP and HAMP, derivatives enriched with an SPE cartridge, and
analyzed as described in the experimental section. After visual examination of individual
extracted ion chromatograms, we found that most of the high intensity peaks were
potentially derivatized carboxylic acids. Both CE-MS and CE-MS/MS methods were used to
verify these results. In the CE-MS mode, we knew that two ions with a mass difference of n
× 28 amu must be found in two CE-MS electropherograms corresponding to BAMP and
HAMP derivatives (n represents the number of the derivatizing tags per labeled molecule
and 28 amu is molecular weight difference between BAMP and HAMP - two CH2 units). In
the CE-MS/MS mode, verification was carried out by analyzing MS/MS spectra for
characteristic fragments found in the standards. MS/MS data for all carboxylic acid
standards were acquired in information dependent acquisition (IDA) mode and the
fragmentation pattern examined. Although MS/MS spectra of these standards did not
provide enough information for precise structural analysis, characteristic fragments were
used to indicate the presence of carboxylic acids and suggest a structural class of carboxylic
acid. For example, all small fatty acids were represented by 107.0, 109.0, 135.0, 177.1, and
219.1 m/z fragments. Mono-carboxylic acids showed fragments from the loss of a C6H9
group (M-84.0) in the derivatizing reagent tag. These fragments were not seen with di- or
tri-carboxylic acids. Phenyl or hetero ring-substituted formic acids showed a fragment at m/z
= 105.0 and loss of the C6H9 group (M-84.0). Figure 4 illustrates the MS/MS fragmentation
pattern of HAMP-derivatized citric acid. Using this approach 59 potential carboxylic acids
were found (Table 2) distributed in 32 peaks (Figure 3).
Carboxylic acids were identified in the following way, it was assumed that ions with a
charge of +2 or +3 correspond to double and triple derivatized molecules, respectively.
Molecular mass of the original (underivatized) compound was calculated from the molecular
mass of the ion found in the MS scan by subtracting the molecular mass of the derivatizing
tag. These calculated molecular masses were then used to search the LIGAND database
(http://www.genome.ad.jp/kegg/ligand.html; released on June 12, 2006 by Kyoto
University, Japan) [46]. Non-carboxyl group-containing compounds were excluded from the
list obtained. The number of potential candidates was further reduced by stipulating that the
number of carboxyl groups should match the charge status of the ion. .
Of 59 candidate ions, 32 were positively identified using standards (labeled S in Table 2).
Seven more were not confirmed with standards but had been previously reported in human
urine (labeled R in Table 2) [15]. Another 7 candidate ions were tentatively identified as
carboxylic acids (labeled L in Table 2) and 13 more ions were not identified (labeled U in
Table 2).
The above results illustrate the strengths of this new method for carboxylic acid analysis.
The permanent positive charge of quaternary amines in the derivatives simplifies the SPE
enrichment step, increases CE selectivity, and enhances the MS signal due to their high
ionization efficiency, presumably by suppression of other non-derivatived molecules in the
sample [23]. The high selectivity and sensitivity obtained through derivatization greatly
facilitate the profiling of carboxylic acids in real biological samples.
3.5 Comparative quantification using isotopically encoded BAMP and BAMP-d9 labeling
reagents
To evaluate the quantification ability of the newly developed method, 24 standard
carboxylic acids were derivatized by chemically identical, but isotopically distinct, reagents.
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Two aliquots of individual carboxylic acid standards were derivatized with BAMP and
BAMP-d9, and mixed at specific ratios for CE-MS analysis. Comparative quantification was
performed by analyzing the extracted ion chromatograms corresponding to the light
(BAMP) and heavy (BAMP-d9) forms of the standard derivatives and their corresponding
MS spectra (Figure 5). Interestingly, no isotope effects were seen in the CE separation as
opposed to HPLC [23]. Both the light and heavy derivatives co-elute and can be
differentiated by MS only (Figure 5). This suggests the superiority of CE over HPLC for
deuterium-coded GSIST derivatives. The range of linearity and derivatization limits of the
standards are summarized in Table 3. Derivatization limit is the lowest concentration of an
analyte that can be derivatized and detected at a signal-to-noise ratio of 3. Unlike
determination of detection limit by diluting an analyte prepared at much higher
concentration, derivatization limits are determined by derivatization of substances at the
concentration they will be analyzed. Thus, the derivatization limit reflects the actual
analytical capability of a method.
The linear ranges varied from 1:1 to 1:8 with correlation coefficients of 0.978 to 0.999.
Derivatization limits were found at 25 μM or less for 20 of 23 standards. The relatively high
derivatization limit (50 μM) of oxaloacetic and oxalic acids may be attributed to their well-
known thermal instability. We have no explanation for the high derivatization limit of quinic
acids (100 μM).
Efficacy of the GSIST comparative profiling strategy using CE-MS was also evaluated in a
biological fluid. Urine samples from two individual rats were derivatized by BAMP and
BAMP-d9 under identical conditions, and mixed in a 1:1 ratio. Following CE-MS analysis,
quantitative profiles of these two samples were obtained from the peak intensities
corresponding to the light and heavy forms (doublet) of individual carboxylic acid
derivatives (Figure 6). If there is no significant biological variation in carboxylic acid
production, the peak intensities of the light and heavy forms of individual metabolites
should be approximately equal between rats. Seventeen of the 31 identified metabolites
showed little or no variation. The other 14 carboxylic acids had a much larger variation in
concentration between rats (e.g. ∼7 fold for suberic acid and ∼10 fold for adipic acid). Since
the comparison was done under identical conditions and the experimental variation was
minimized, these differences likely reflect individual variations in metabolism.
4 Concluding remarks
Based on the results presented above it is concluded that a pre-charged deuterium-labeled
coding agent for carboxylic acid metabolites enhances both detection sensitivity and
quantification in CE-MS and CE-MS/MS. The described method enables comprehensive,
sensitive, and comparative profiling of carboxylic acids in biological fluids such as urine.
Fifty-nine potential carboxylic acids were found in pooled urine with 32 positively identified
using standards and 14 tentatively assigned. Comparative analysis of two samples from
individual rats illustrated the capability of comparative metabolite profiling. Since no
sample preparation is required before derivatization, it is concluded the method can be
applied to a wide range of biological samples for profiling, biomarker discovery, analysis of
drug metabolism, and pharmacokinetics of carboxylic acid-related compounds.
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Figure 1.
Derivatization scheme for carboxylic acids.
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Figure 2.
CE-ESI-MS base peak electropherogram of BAMP and HAMP derivatives of standard
carboxylic acids. Experimental conditions: carboxylic acid concentration, 100 M each;
capillary, bare fused silica 50 m i.d. × 100 cm; electrolyte, 1M formic acid; separation, 30kV
+ 0.2psi forward pressure; injection, 2 s at 5 psi; sheath flow, 1 l/min of 50% (v/v) methanol
with 0.1% (v/v) formic acid in water. Trace A: BAMP derivatives. Trace B: HAMP
derivatives. Peak identifications are provided in Table 1.
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Figure 3.
CE-ESI-MS base peak chromatogram of BAMP and HAMP derivatives of the pooled rat
urine. Trace A: BAMP derivatives. Trace B: HAMP derivatives. Peak identifications are
provided in Table 2. Experimental conditions are the same as in Figure 2.
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Figure 4.
Tandem mass spectrum and fragmentation of HAMP derivative of citric acid. Experimental
conditions are the same as in Figure 2.
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Figure 5.
Extracted ion chromatograms of representative carboxylic acids at specific light/heavy
concentration ratios. Upper traces (a, b, c) are light-form derivatives; lower traces are heavy-
form derivatives. Corresponding MS spectrum (a', b', c') of the pairs of light- and heavy-
form derivatives are also shown. a, a': Malonic acid at ratio 8:1 (light/heavy); b, b': formic
acid at ratio 2:1; c, c': benzoic acid at the ratio 1:1. Other experimental conditions are the
same as in Figure 2.
Yang et al. Page 15
Electrophoresis. Author manuscript; available in PMC 2012 October 18.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 6.
Distribution of carboxylic acids in urine from two normal rats. Samples A and B were
derivatized with BAMP and BAMP-d9, respectively, and mixed at the ratio of 1:1. The
results provided are the averages from 5 analyses of each sample. The experimental
conditions are the same as in Figure 2. The numbers on the x-axis correspond to the
following carboxylic acids: 1. nicotinic acid; 2. oxaloacetic acid; 3. oxalic acid; 4. succinic
acid; 5. citric acid; 6. malic acid; 7. ketoglutaric acid; 8. methylcitric acid; 9. adipic acid; 10.
suberic acid; 11. isocitric acid; 12. 3-methylgluteric acid; 13. formic acid;14. carbonic acid;
15. glyoxylic acid; 16. acetic acid; 17. propionic acid; 18. pyruvic acid; 19. oxamic acid; 20.
lactic acid; 21. butyric acid, isobutyric acid; 22. benzonic acid; 23. 5-methylfuran-2-
carboxylic acid; 24. 2-hydroxy-2-ethyl-succinic acid; 25. phenylacetic acid; 26. 3-
indoleacetic acid; 27. 3-phenyl-propionic acid; 28. α-hydroxyphenylacetic acid; 29. suberic
acid; 30. hippuric acid; 31. nalidixic acid.
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